Answers are grounded in this paper and cite their sources.
Prostate cancer, a leading cause of cancer-related mortality in men, often progresses to metastatic castration-resistant prostate cancer (mCRPC) despite advances in treatment with androgen-receptor pathway inhibitors (ARPIs) and taxanes. Recent genomic studies have highlighted that alterations in DNA damage repair genes, notably BRCA1 and BRCA2, play a significant role in the progression of prostate cancer. Synthetic lethality, characterized as cell death caused by the concurrent loss of two distinct DNA repair pathway, has emerged as a promising therapeutic approach in the treatment of mCRPC, particularly for patients with BRCA mutations. Loss of BRCA function results in defects in double-strand break repair, making these cancer cells highly dependent on poly(ADP-ribose) polymerase 1/2 (PARP1/2)-mediated single-strand break repair. PARP inhibitors, such as olaparib, rucaparib, and talazoparib, exploit this vulnerability by inhibiting PARP activity and “trapping” PARP on DNA, leading to lethal double-strand breaks that BRCA-deficient cells cannot repair. Clinical trials have shown significant survival benefits for mCRPC patients with BRCA mutations treated with PARP inhibitors, and overtime, FDA approvals have paved the way for these therapies to become part of standard treatment regimens. Moreover, combining PARP inhibitors with other therapies like ARPIs and immunotherapy, has demonstrated promising results. Despite these advances, challenges such as therapeutic resistance against PARP inhibition, treatment-related toxicities and side-effects, and cost ineffectiveness remain significant hurdles. Future research efforts are focused on improving the effectiveness of PARP inhibitors-induced synthetic lethality, understanding resistance pathways, and ensuring wider adaptability, with an ultimate goal to alleviate the global prostate cancer burden.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: